XP【XPBR31】銘柄情報 | ADVFN

US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

登録

ホーム
投資
株式
ブラジル
BOV
XP Inc (XPBR31) 銘柄情報

XP Inc (XPBR31)

91.92

1.76

(1.95%)

終了 11月24日 5:55AM

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

92.64

買値

91.00

売値

93.17

出来高

285,924

90.36 日の範囲 93.50

87.64 52 週間の範囲 131.99

時価総額

前日終値

90.16

始値

91.09

時刻

最終取引時間

財務取引量

R$ 26,332,457

VWAP

92.096

平均取引量 (3 か月)

440,287

発行済株式数

436,776,000

配当利回り

15.29%

PER

1.78

1 株当たり利益 (EPS)

8.93

歳入

15.09B

純利益

3.9B

セクター

Security Brokers & Dealers

業界

Security Brokers & Dealers

ウェブサイト

www.xpinc.com

本社

Grand Cayman, Cym

設立

-

XP Inc is listed in the Security Brokers & Dealers sector of the ボベスパ (ブラジル) with ticker XPBR31. The last closing price for XP was R$90.16. Over the last year, XP shares have traded in a share price range of R$ 87.64 to R$ 131.99.

XP currently has 436,776,000 shares in issue. The market capitalisation of XP is R$39.38 billion. XP has a price to earnings ratio (PE ratio) of 1.78.

No news to show yet.

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-4.47	-4.60302749459	97.11	98.37	89.74	587311	92.74803272	DR
4	-7.87	-7.83006666003	100.51	104.83	89.74	406121	98.33024591	DR
12	-11.99	-11.4594284622	104.63	110.49	89.74	440287	100.33813791	DR
26	-14.18	-13.2746676652	106.82	111.06	87.64	460519	99.42175041	DR
52	-18.86	-16.9147982063	111.5	131.99	87.64	571871	111.89924868	DR
156	-73.47	-44.2297272891	166.11	187.46	53.82	706444	108.3132342	DR
260	-125.86	-57.6018306636	218.5	233.2	53.82	757245	118.80239328	DR

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
AMER3Americanas SA	R$ 8.70 (14.78%)	13.15M
OIBR3Oi	R$ 1.46 (9.77%)	11.56M
IFCM3Infracommerce Caxaas S.A.	R$ 0.12 (9.09%)	1.92M
HETA4Hercules SA Fabrica De Talheres	R$ 6.98 (8.39%)	200
TECN3Technos SA	R$ 5.74 (8.30%)	333.8k
MERC4Mercantil Financeria S.A. - Credito Financiamento e Investimento	R$ 8.90 (-12.66%)	6.5k
VSTE3Veste S.A. Estilo	R$ 8.42 (-8.97%)	5.73k
FRIO3Metalfrio Solutions Sa	R$ 145.50 (-7.91%)	1.3k
AMBP3Ambipar Participacoes e Empreendimentos SA	R$ 170.00 (-7.61%)	139.2k
ONCO3Oncoclinicas Brasil Servicos Medico	R$ 3.33 (-7.24%)	5.29M
PETR4Petroleo Brasileiro S.A. Petrobras	R$ 39.42 (3.98%)	85.23M
HAPV3Hapvida Participacoes Investimento SA	R$ 2.98 (3.47%)	56.29M
COGN3CognaEducacao SA	R$ 1.39 (5.30%)	35.3M
RAIZ4Raizen S.A	R$ 2.60 (7.00%)	34.25M
CVCB3CVC Brasil Operadora E Agencia De Viagens SA	R$ 2.53 (5.42%)	34.17M

Seminole Red

Seminole Red 4分前

I hope we have that choice.....

dexprs

For the last 95 years following two 20+% years on the market the average return had been an 8.9% gain. Some think we should have a down year in 2025, but the stats do not confirm that.

Seminole Red

Seminole Red 5分前

tw0122

QuantumOasis152

QuantumOasis152 5分前

Glen, I am a big buyer at .62 cents.
nice to see someone else recognize risk free high potential real estate.
Would you give commentary to how you see your charts?

nelson1234

nelson1234 6分前

My son was just made VP at BBT & MSD Partners, he's 26. Who wudda thunk? Especially since he's not an Ivy League or equiv grad. Anyway, nice thanksgiving news..........

1vman

***** 🤪YESSIR !!!🟥 Lose lose !! 🟥🟥🟥 huge reverse split on the table for this stock to survive

ENOUGH SAID HUZZAH !!!

trader53

trader53 8分前

DPLS - I'm Dreaming of a DPLS Christmas!

https://www.youtube.com/watch?v=GJ36gbGlm8Y

MartinLutherKing

MartinLutherKing 9分前

$10.00 explosions coming brother
On September 17, we found out that the first 2 patients were dosed. I would hope that we receive information on month 3 about those patients continuing treatment as well as dose updates.

Per the clinical trial website:

"Detai

flipper44

flipper44 9分前

Let me give you one highlight from a link in my last post.

Hyperactivating Stimuli Protect against Established Tumors That Are Resistant to Anti-PD1 Therapy

To determine if hyperactivating stimuli could be harnessed as a cancer immunotherapy, we examined anti-tumor resp

trader53

trader53 9分前

WCVC - I'm Dreaming of a WCVC Christmas!

https://www.youtube.com/watch?v=GJ36gbGlm8Y

NeoSunTzu

NeoSunTzu 10分前

I agree with those who say if Bessant is good enough for Ackman he is good enough for us. But just remember, a lot of moles made it into the previous Trump admin, and D.C. is infested with them. The other side will not just cower and obey. I'm positive his team will be better this time around, but p

Seminole Red

Seminole Red 10分前

more Floyd type riots coming from the dems over Illegal migrants

1vman

***** Wowzah Pow Were2the 🚽GME🚽 massive dilution here

ENOUGH SAID HUZZAH🤪 !!!

FMDK

What do I expect from you? Of course nothing! In your own interest, you should just slowly wake up and acknowledge reality.

Doc logic

Doc logic 11分前

flipper44,

I believe you are definitely on to something. A specific lipid trigger could quite possibly disrupt lipid balance in cancer cells and that will almost instantly cause cancer cell death. Finding the right interface to disrupt lipid balance was thought to be a potential Hol

nelson1234

nelson1234 11分前

ssk, congrats on your recent batch of trading successes!

Vancmike

Vancmike 11分前

Rodney,

I always enjoy your well thought out posts. I have saved many for future reference. As you, I have written letters to Senators and Congressman. I am currently working on another letter. A couple of questions please, if I may;

1. In your post "For the purpose of

ttottip

ttottip 12分前

Maybe the $50's today.

racerdave42

racerdave42 12分前

weedtrader420

weedtrader420 12分前

Every person that holds XRP gets a Ferrari😁🏎️😂🤣😂

1vman

***** LMAO !!! 🚽OMHE🚽 Buys ? With no volume ? shorts ? theres no shorts on a 5 zero stock

ENOUGH SAID HUZZAH🤪 !!!

justus1

justus1 13分前

Totally Agree! Maybe being a Friday hurt us and the jury didn't want to come back? Think they needed more time to think this through. Thirty years ago I sat on a rewards case for a family who was suing the city over the death of their daughter and their son being shot at the same time by a LA street

Global X Robotics & Arti...

Fd Technologies Public

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約